All News about Lexaria Bioscience Corp WT
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
Lexaria is Receiving Four New Patents
April 20, 2023
Via ACCESSWIRE
![](https://cdn.benzinga.com/files/images/story/2023/03/02/louis.jpg?width=1200&height=800&fit=crop)
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
Lexaria's Human Clinical Hypertension Study a Success
October 27, 2022
Via ACCESSWIRE
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
Lexaria Discusses Valuation Metrics for Biotech Industry
August 11, 2022
Via ACCESSWIRE
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
Via ACCESSWIRE
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
Lexaria Releases Annual Letter from the CEO
January 13, 2023
Via ACCESSWIRE
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
Lexaria Receives First Granted Patent in Canada
December 29, 2022
Via ACCESSWIRE
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
Via ACCESSWIRE
CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Begins Dosing in Its Human Oral Nicotine Study
December 20, 2022
Via CannabisNewsWire
Topics
Intellectual Property
Exposures
Intellectual Property
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
Lexaria’s Human Oral Nicotine Study Begins Dosing
December 20, 2022
Via ACCESSWIRE
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
Via ACCESSWIRE
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
Via ACCESSWIRE
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
![](https://www.newmediawire.com/media/sites/270/images/social-image.jpg)
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
Lexaria Welcomes Dr. Catherine Turkel to its Board of Directors
September 02, 2022
Via ACCESSWIRE
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
Lexaria Receives New Patent in Mexico
August 31, 2022
Via ACCESSWIRE
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
![](https://cdn.benzinga.com/files/images/story/2022/07/27/drug_development_cottonbro_and_chokniti_khongchum_by_pexels.jpg?width=1200&height=800&fit=crop)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.